Cargando…
Effects of nilotinib on platelet function in patients with chronic myeloid leukemia in chronic phase
BACKGROUND: Tyrosine kinases are highly expressed in platelets and play an important role in their activation process. Some studies have reported the blocking effects of tyrosine kinase inhibitors on different platelet functions. OBJECTIVES: Evaluate the effects of nilotinib on platelets aggregation...
Autores principales: | Alqasim, Alauldeen Mudhafar Zubair, Obaid, Ghasaq Mohsin, Yaseen, Yusra Ghaith, Alwan, Alaa Fadhil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594045/ https://www.ncbi.nlm.nih.gov/pubmed/31293883 http://dx.doi.org/10.1016/j.lrr.2018.05.003 |
Ejemplares similares
-
Prominent hemophagocytosis in cerebrospinal fluid in a patient with pneumococcal meningitis
por: Alqasim, Alauldeen Mudhafar Zubair, et al.
Publicado: (2021) -
Evaluation of the Safety of Imatinib Mesylate in 200 Iraqi Patients with Chronic Myeloid Leukemia in the Chronic Phase: Single-Center Study
por: Matti, Bassam Francis, et al.
Publicado: (2013) -
Development and targeted use of nilotinib in chronic myeloid leukemia
por: Fava, Carmen, et al.
Publicado: (2009) -
Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
por: Na, Yoo Jin, et al.
Publicado: (2021) -
Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
por: DeRemer, David L, et al.
Publicado: (2011)